Jeffrey F Waring

Title: The Innovations of Jeffrey F. Waring

Introduction

Jeffrey F. Waring is a notable inventor based in Franklin, Wisconsin, who has made significant contributions to the field of medicine. He holds two patents that focus on innovative methods for treating diseases related to elevated serum concentrations of UGT1A1 substrates. His work is particularly relevant in the context of unconjugated hyperbilirubinemia.

Latest Patents

Waring's latest patents include a method for treating a disease, disorder, or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate. This invention is directed towards inducing UGT1A1 isoform expression for treatment purposes. The method involves administering an effective amount of ritonavir to a subject. Specifically, it aims to treat unconjugated hyperbilirubinemia through UGT1A1 induction.

Career Highlights

Jeffrey F. Waring is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions that address critical health issues. Waring's contributions have been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Waring has collaborated with notable colleagues such as Dale J. Kempf and Richard J. Bertz. These collaborations have fostered a productive environment for innovation and research within the company.

Conclusion

Jeffrey F. Waring's contributions to medical innovation through his patents and work at Abbott Laboratories Corporation highlight his commitment to improving healthcare. His methods for treating elevated serum concentrations of UGT1A1 substrates represent significant advancements in the field.